The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …

There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …

Abstract The 2019 coronavirus disease (COVID-19), triggered by the severe acute
respiratory syndrome coronavirus (SARS-CoV-2), has seen numerous individuals undergo …

Cognitive impairment, depression and (mental) fatigue represent the most frequent
neuropsychiatric symptoms of the post-COVID syndrome. Neuroinflammation, oxidative …

Purpose New-onset chronic musculoskeletal (MSK) pain is one of the common persistent
symptoms in Long COVID (LC). This study investigated its clinical characteristics, underlying …

Antiviral drugs are important for the coronavirus disease 2019 (COVID-19) response, as
vaccines and antibodies may have reduced efficacy against severe acute respiratory …

Background: Dysautonomia seems to be important for the pathophysiology of
psychosomatic diseases and, more recently, for long COVID. This concept may explain the …

This prospective, randomized, controlled clinical trial assessed the therapeutic effects of
major ozone autohemotherapy (O 3-MAH) in patients with post-acute sequelae of COVID-19 …

Nearly four years after its first appearance, and having gone from pandemic to endemic, the
SARS-CoV-2 remains out of control globally. The purpose of this study was to evaluate the …

Full article: Long COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs
for cardiopulmonary complications Skip to Main Content Taylor and Francis Online homepage …